Elizabeth B Odom1, David L Eisenberg2, Ida K Fox3. 1. Washington University School of Medicine, Division of Plastic and Reconstructive Surgery. 2. Washington University School of Medicine, Department of Obstetrics and Gynecology. 3. Washington University School of Medicine, Division of Plastic and Reconstructive Surgery. Electronic address: foxi@wudosis.wustl.edu.
Abstract
OBJECTIVES: We aim to describe our experiences and identify patients who may benefit from referral to a peripheral nerve surgeon for removal of contraceptive subdermal implants in which neurovascular injury may occur, and describe a treatment pathway for optimal care. STUDY DESIGN: We reviewed the charts of 22 patients who were referred to the Division of Family Planning for difficult removal of etonogestrel contraceptive implants between January 1, 2014, and April, 1 2016. Of these, five were referred to a peripheral nerve surgeon due to pain or location of the implant. We evaluated and described these cases and, from our findings, developed recommendations for care in a multidisciplinary team approach. RESULTS: Two patients reported pain, including one with four previous failed removal attempts. In the two patients with pain, the implants were adherent to a sensory nerve. In another, the implant was within the biceps muscle and difficult to locate. In all cases, ultrasound imaging, general anesthesia and a wide exposure allowed for safe removal and good outcomes. Our multidisciplinary care approach has elucidated important referral and technical considerations that improve patient care and safety. CONCLUSION: When necessary, multidisciplinary care with a Family Planning expert and possibly a peripheral nerve surgeon may be beneficial in safely removing etonogestrel contraceptive implants that would be difficult or risky to remove in an ambulatory setting.
OBJECTIVES: We aim to describe our experiences and identify patients who may benefit from referral to a peripheral nerve surgeon for removal of contraceptive subdermal implants in which neurovascular injury may occur, and describe a treatment pathway for optimal care. STUDY DESIGN: We reviewed the charts of 22 patients who were referred to the Division of Family Planning for difficult removal of etonogestrel contraceptive implants between January 1, 2014, and April, 1 2016. Of these, five were referred to a peripheral nerve surgeon due to pain or location of the implant. We evaluated and described these cases and, from our findings, developed recommendations for care in a multidisciplinary team approach. RESULTS: Two patients reported pain, including one with four previous failed removal attempts. In the two patients with pain, the implants were adherent to a sensory nerve. In another, the implant was within the biceps muscle and difficult to locate. In all cases, ultrasound imaging, general anesthesia and a wide exposure allowed for safe removal and good outcomes. Our multidisciplinary care approach has elucidated important referral and technical considerations that improve patient care and safety. CONCLUSION: When necessary, multidisciplinary care with a Family Planning expert and possibly a peripheral nerve surgeon may be beneficial in safely removing etonogestrel contraceptive implants that would be difficult or risky to remove in an ambulatory setting.
Authors: Paul D Blumenthal; Kristina Gemzell-Danielsson; Maya Marintcheva-Petrova Journal: Eur J Contracept Reprod Health Care Date: 2008-06 Impact factor: 1.848
Authors: Diana Mansour; Martyn Walling; Derek Glenn; Christian Egarter; Olivier Graesslin; Josef Herbst; Ian S Fraser Journal: J Fam Plann Reprod Health Care Date: 2008-04
Authors: Gottfried Wechselberger; Dolores Wolfram; Petra Pülzl; Elisabeth Soelder; Thomas Schoeller Journal: Am J Obstet Gynecol Date: 2006-04-21 Impact factor: 8.661
Authors: Ioannis Sarris; Felix Göbel; Michael Gainer; Dimitris G Vardakas; Molly T Vogt; Dean G Sotereanos Journal: J Reconstr Microsurg Date: 2002-11 Impact factor: 2.873
Authors: Melissa C Matulich; Melissa J Chen; Natasha R Schimmoeller; Jennifer K Hsia; Suji Uhm; Machelle D Wilson; Mitchell D Creinin Journal: Obstet Gynecol Date: 2019-10 Impact factor: 7.661